Anterogen.Co.,Ltd.
KOE: 065660.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Seong-Gu Lee
- Employees
- 35
- Headquarters
- Seoul, South Korea
- IPO year
- 2016
- Market cap
- ₩327.7B
- Website
- http://anterogen.com
Loading 065660…
Loading profile data…Frequently asked questions about 065660
What does Anterogen.Co.,Ltd. (065660.KQ) do?
Anterogen.Co.,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. The company offers medicines, including Cupistem injection, an adipose stem cell product that is used for the treatment of Crohn's fistula; Queen...
Where does 065660.KQ trade?
Anterogen.Co.,Ltd. (065660.KQ) trades on the KOSDAQ.
What sector is 065660.KQ in?
Anterogen.Co.,Ltd. (065660.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Anterogen.Co.,Ltd.?
Seong-Gu Lee is the chief executive officer of Anterogen.Co.,Ltd. (065660.KQ).
Where is Anterogen.Co.,Ltd. headquartered?
Anterogen.Co.,Ltd. is headquartered in South Korea.
Does 065660.KQ pay a dividend?
Anterogen.Co.,Ltd. (065660.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 065660.KQ go public?
Anterogen.Co.,Ltd. (065660.KQ) completed its initial public offering in 2016.